A Study of Daily Living Activity Levels in Patients with Total Hip Replacement

Overview

About this study

The purpose of this study is to assess daily living activity levels of patients before and after total hip replacement, and to correlate these activities of daily living to those usually obtained with disease-specific questionnaires.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Male or Female patients
Ages 20 to 85
With unilateral osteoarthritis (DJD) who are surgical candidates for total hip arthroplasty
Study participants must be able to give informed consent

Exclusion Criteria:

Significant proximal femoral deformity (post SCFE, Perthes, DDH)
- Acetabular dysplasia (ANY CROWE)
- Inflammatory arthritis
- Septic arthritis
- Osteomyelitis
- Prior infection of hip joint
- Significant leg length discrepancy (>4cm)
- Osteoporosis
- Arthrodesis of the affected hip
The presence of infections, highly communicable diseases, e.g. AIDS, active tuberculosis, venereal disease, hepatitis
Significant neurological or musculoskeletal disorder or disease that may adversely affect normal gait or weight bearing
Presence of previous prosthetic hip replacement device (any type) in the operative hip
Active Metastatic disease
Active major Psychiatric illness
Active Drug or alcohol abuse
BMI > 40
Patients that are known to be pregnant
Actively failing contralateral hip replacement

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Kenton Kaufman, Ph.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Kenton Kaufman, Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials